Samuel Whiting's Net Worth

-$317

Estimate Recalculated Feb 7, 2024 03:48PM EST

Who is Samuel Whiting?

Samuel Whiting does not have any significant net worth to report based on the numbers we have. This is based on reported shares in Tempest Therapeutics, Inc..

SEC CIK

Samuel Whiting's CIK is 0001870373

Past Insider Trading and Trends

2021 was Samuel Whiting's most active year for acquiring shares with 4 total transactions. Samuel Whiting's most active month to acquire stocks was the month of May. 2022 saw Samuel Whiting paying a total of $8,168.16 for 86,380 shares, this is the most they've acquired in one year.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Tempest Therapeutics, Inc. (TPST) Snapshot price: $4.13

Chief Medical Officer

Samuel Whiting owns 1,901 units of Common Stock which is worth $7,851.13. From 2021 to 2023 Samuel Whiting acquired a total of 1,901 shares in Tempest Therapeutics, Inc. at a cost of $8,168.16.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jan 3
Form 4
—
0
—
—
0
Oct 11
Form 4
—
0
—
—
0
Jan 3
Form 4
—
0
—
—
0
Jun 21
Form 4
+845.77%
1.7K
$4.80
$8,168.16
1.9K
Jan 6
Form 4
—
0
—
—
0
Jan 4
Form 4
∞
201
—
—
201
Jun 25
Form 3
—
0
—
—
0
No matching records found